A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/23/1997	WO1997039120A2 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997	WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	WO1997039114A1 AN ENZYME WITH β-1,3-GLUCANASE ACTIVITY
10/23/1997	WO1997039111A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	WO1997039110A1 Transgenic plants expressing geminivirus genes
10/23/1997	WO1997039105A1 Mad-related genes in the human
10/23/1997	WO1997039102A2 Secreted proteins
10/23/1997	WO1997039034A1 Means for detecting bacteria of the taylorella equigenitalis species and their biological applications
10/23/1997	WO1997039033A1 Purification of factor viii complex by immunoaffinity chromatography
10/23/1997	WO1997039032A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	WO1997039031A1 Glucagon-like peptide-2 analogs
10/23/1997	WO1997039030A2 Secreted proteins
10/23/1997	WO1997039028A1 Mutant plasminogen activator-inhibitor type 1 (pai-1) and uses thereof
10/23/1997	WO1997039027A1 Stabilization of therapeutic hemoglobin compositions
10/23/1997	WO1997039026A1 Novel peptides and nootropic agent
10/23/1997	WO1997039025A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
10/23/1997	WO1997039024A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/23/1997	WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997	WO1997039022A1 Novel compounds
10/23/1997	WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997	WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997	WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997	WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
10/23/1997	WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997	WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997	WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997	WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
10/23/1997	WO1997038731A1 Immunoliposomes that optimize internalization into target cells
10/23/1997	WO1997038729A1 In vivo gene transfer methods for wound healing
10/23/1997	WO1997038728A1 Combination therapy for androgenic alopecia with antisense oligonucleotides and minoxidil
10/23/1997	WO1997038722A1 Novel compounds
10/23/1997	WO1997038721A1 Novel compounds
10/23/1997	WO1997038720A1 Novel compounds
10/23/1997	WO1997038719A1 Novel compounds
10/23/1997	WO1997038718A1 Novel compounds
10/23/1997	WO1997038717A1 Novel compounds
10/23/1997	WO1997038716A1 Novel compounds
10/23/1997	WO1997038715A1 Novel compounds
10/23/1997	WO1997038714A1 Novel compounds
10/23/1997	WO1997038712A1 Intestinal trefoil proteins
10/23/1997	WO1997038709A1 Use of growth hormone
10/23/1997	WO1997038708A1 Modulating epithelial-mesenchymal interactions
10/23/1997	WO1997038707A1 Method and device for delivery of apoptosis-inducing molecules
10/23/1997	WO1997038706A1 Glycopeptide compounds
10/23/1997	WO1997038705A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997	WO1997038704A1 Treatment of bone disorders with adrenomedullin
10/23/1997	WO1997038703A1 Chimeric isoprenoid synthases and uses thereof
10/23/1997	WO1997038702A1 Covalently-linked glycopeptide dimers
10/23/1997	WO1997038700A1 Oxygen-enriched atmosphere for enhancing the effective life of oxygen-delivery agents
10/23/1997	WO1997038697A1 Sensitization of cells to radiation and chemotherapy
10/23/1997	WO1997038689A2 Enteric-coated pharmaceutical compositions of mycophenolate
10/23/1997	WO1997038685A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/23/1997	WO1997038670A1 Compositions for the removal of dental plaque
10/23/1997	WO1997038669A1 Compositions for the removal of dental plaque
10/23/1997	WO1997038664A2 A method of treating cancer
10/23/1997	WO1997038593A1 Diabetic supplement bar
10/23/1997	WO1997038584A1 Inhibition of endogenous gastrin expression for treatment of colorectal cancer
10/23/1997	WO1997035005A3 Cftr gene regulator
10/23/1997	WO1997034586A3 Device and method for treating ophthalmic diseases
10/23/1997	WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997	WO1997032019A3 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses
10/23/1997	WO1997031657A3 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumors
10/23/1997	WO1997031612A3 Mammalian endonuclease iii, and diagnostic and therapeutic uses thereof
10/23/1997	WO1997031114A3 Polynucleotides and aminoacid sequences from staphylococcus aureus
10/23/1997	WO1997031019A3 Antipathogenic peptides and compositions comprising them
10/23/1997	WO1997028187A3 Multivalent chimeric peptides as microbicides
10/23/1997	WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997	WO1997026853A3 Dna encoding galanin galr2 receptors and uses thereof
10/23/1997	WO1997024446A3 Gene delivery vehicle-targeting ligands
10/23/1997	WO1997021812A3 Mammalian chemokine ccf8 and chemokine receptor cckr3
10/23/1997	WO1996034890A3 Inhibitors of fibrin cross-linking and/or transglutaminases
10/23/1997	DE19615710A1 Verfahren zur Gewinnung und Anwendung eines biologisch aktiven Eiweisstoffes - Kollagenfragment HF-COLL-18/514cf - in partiell aufgereinigter und synthetischer Form aus Körperflüssigkeiten zur Beeinflussung des Zellwachstums und der Diagnose von Kollagenerkrankungen sowie der Osteoporose Methods for obtaining and application of a biologically active Eiweisstoffes - collagen fragment HF-COLL-18 / 514cf - in partially purified form from body fluids and synthetic for influencing the cell growth and the diagnosis of collagen diseases and osteoporosis
10/23/1997	CA2252228A1 Treatment of bone disorders with adrenomedullin
10/23/1997	CA2252225A1 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997	CA2252099A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
10/23/1997	CA2252082A1 Hybrid interferon compositions and methods of use
10/23/1997	CA2251955A1 A method of treating cancer
10/23/1997	CA2251945A1 Antisense inhibitors of vascular endothelial growth factor (vefg/vpf) expression
10/23/1997	CA2251925A1 Compositions for the removal of dental plaque
10/23/1997	CA2251818A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	CA2251797A1 Novel peptides and nootropic agent
10/23/1997	CA2251724A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	CA2251716A1 Sensitization of cells to radiation and chemotherapy
10/23/1997	CA2251631A1 Intestinal trefoil proteins
10/23/1997	CA2251292A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
10/23/1997	CA2251115A1 Novel rantes homolog from prostate
10/23/1997	CA2251071A1 Use of an osmolyte in the preparation of a medicament for treating complications resulting from ischemia
10/23/1997	CA2250975A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/23/1997	CA2250907A1 Use of growth hormone
10/23/1997	CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/23/1997	CA2241051A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997	CA2224859A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	CA2219151A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/22/1997	EP0802199A2 Covalently bound dimers of glycopetide antibiotics
10/22/1997	EP0801951A2 Novel uses of Il-4 and/or Il-10, and antibodies against the same
10/22/1997	EP0801686A1 Process for preparing cyclosporin a
10/22/1997	EP0801685A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy
10/22/1997	EP0801679A1 Monoclonal antibodies which promote central nervous system remyelination
10/22/1997	EP0801676A2 New artificial tissue, method for the production and the use thereof
10/22/1997	EP0801658A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples

1 ... 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 ... 3163